
|Videos|November 15, 2022
Dr. Morris on challenge of fixed reimbursement vs rising inflation in urology
Author(s)Urology Times staff
“From just a regular business sense, we can’t raise prices to offset some of our supply cost problems,” says David Morris, MD.
Advertisement
At the
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves first-line Zenflow system for the treatment of BPH
2
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC
5


















